TOLREMO receives 39 million US dollars in investments TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The…martin09.21.2023
Mazars opens tenth Swiss office in Basel Mazars is now also present in Basel with a subsidiary as of September 1. This…martin09.14.2023
Forty51 Ventures invests to found Mysthera Therapeutics Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also…martin08.22.2023
Spexis receives capital commitment of 2.5 million US dollars Investors have made an additional capital commitment to Spexis AG, based in the Basel Area.…martin08.15.2023
Worg secures financing of 130 million Swiss francs The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area,…martin08.03.2023
Tenpoint aims to make vision loss reversible The startup Tenpoint Therapeutics has started operations with a funding round of 70 million US…annett07.13.2023
Roche and ETH training the next generation of researchers Roche, the Basel-based life sciences firm, and the Swiss Federal Institute of Technology in Zurich…annett07.06.2023
Clear Solutions Labs seeks to benefit from the Basel Area The founders of Clear Solutions Laboratories are putting together a team of experts in the…martin06.27.2023
How digital transformation is driving pharmaceutical innovation in Basel How are digital innovations such as artificial intelligence (AI) and machine learning (ML) helping to…martin06.21.2023
Medical informatics is shaping Switzerland’s digital future Switzerland is at the forefront of embracing medical informatics, and innovative biotech hubs – such…martin06.15.2023